Perceptive Advisors’s Clover Health Investments CLOV Stock Holding History

Perceptive Advisors’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,500,000	Closed	-$1.27M	–	98
2023 Q1	$1.27M	Hold	1,500,000	–	–	0.04%	92
2022 Q4	$1.39M	Hold	1,500,000	–	–	0.04%	89
2022 Q3	$2.55M	Hold	1,500,000	–	–	0.07%	97
2022 Q2	$3.21M	Hold	1,500,000	–	–	0.1%	87
2022 Q1	$5.33M	Hold	1,500,000	–	–	0.11%	102
2021 Q4	$5.58M	Hold	1,500,000	–	–	0.09%	114
2021 Q3	$11.1M	Hold	1,500,000	–	–	0.16%	96
2021 Q2	$20M	Hold	1,500,000	–	–	0.26%	84
2021 Q1	$10.3M	Buy	+1,500,000	New	+$16.9M	0.13%	98

Other funds holding CLOV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

JAM

Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Perceptive Advisors's CLOV Position: Q2 2023 in Review

Perceptive Advisors sold out of Clover Health Investments (CLOV) in Q2 2023, closing a stake of 1,500,000 shares — an estimated $1.27M sold.

Perceptive Advisors first reported a position in CLOV in Q1 2021 and held it in 9 quarters. The position peaked at $20M in Q2 2021. 145 funds tracked by Wall St. Rank hold CLOV as of Q2 2023.

Perceptive Advisors reported no remaining Clover Health Investments position as of Q2 2023 after selling out during the quarter.
Perceptive Advisors sold 1,500,000 Clover Health Investments shares in Q2 2023, an estimated $1.27M.
Perceptive Advisors first reported a position in Clover Health Investments in Q1 2021 and held it in 9 quarters.
Perceptive Advisors's Clover Health Investments position peaked at $20M in Q2 2021.
145 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2023.

Based on Perceptive Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.